Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study Evaluating Antithyroid Drug Dose Adjustment Based on AI-Powered Monitoring of Thyrotoxicosis Using Glandy HYPER in Patients With Graves' Disease

NCT07857421 is registered in ClinicalTrials.gov with THYROSCOPE INC. as lead sponsor.

NCT NCT07857421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07857421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study Evaluating Antithyroid Drug Dose Adjustment Based on AI-Powered Monitoring of Thyrotoxicosis Using Glandy HYPER in Patients With Graves' Disease
Lead sponsor
THYROSCOPE INC.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 20, 2026
Completion date
July 31, 2027
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

graves disease, hyperthyroidism, thyrotoxicosis